The field of regenerative medicine is rapidly advancing, and BioXtek is at the forefront of this revolution. By harnessing the power of human placental
In a groundbreaking move, the United States Food and Drug Administration has recently given its nod to two pioneering cell-based gene therapies, Casgevy and